Edwards Lifesciences Corp (NYSE:EW)
| 69.65 Delayed Data As of 4:00pm ET |  -0.53 / -0.76%Today’s Change | 67.13 Today|||52-Week Range 94.87 | -6.65% Year-to-Date |
Latest EW News | Press Releases
| ITGR or EW: Which Is the Better Value Stock Right Now? Sep 21 / Zacks.com - Paid Partner Content | Unveiling Edwards Lifesciences (EW)'s Value: Is It Really Priced Right? A Comprehensive Guide Sep 20 / GuruFocus News - Paid Partner Content |
| Edwards Lifesciences Corp (EW): A Deep Dive into Its Financial Metrics and Competitive Strengths Sep 20 / GuruFocus News - Paid Partner Content | Here's Why You Should Invest in Edward Lifesciences (EW) Now Sep 13 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 70.18 |
| Today’s open | 70.79 |
| Day’s range | 69.54 - 70.79 |
| Volume | 3,073,962 |
| Average volume (3 months) | 3,092,704 |
| Market cap | $44.5B |
Data as of 4:00pm ET, 09/22/2023
Growth & Valuation
| Earnings growth (last year) | +1.95% |
| Earnings growth (this year) | +2.89% |
| Earnings growth (next 5 years) | +10.29% |
| Revenue growth (last year) | +2.86% |
| P/E ratio | 30.8 |
| Price/Sales | 8.65 |
| Price/Book | 7.67 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| STESTERIS plc | +3.26 | +1.48% |
| SNNSmith & Nephew PLC | -0.05 | -0.20% |
| ---- | ||
| GMEDGlobus Medical Inc | -0.34 | -0.67% |
Data as of 3:59pm ET, 09/22/2023
Financials
| Next reporting date | October 25, 2023 |
| EPS forecast (this quarter) | $0.63 |
| Annual revenue (last year) | $5.4B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 28.28% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
